“CJC-1295 no DAC”
A biohacking-community thread asking about CJC-1295 without DAC, likely covering dosing, timing, and how the shorter-acting form is used in reported GH-secretagogue protocols.
Community reports — not medical advice
These are community-reported observations, not clinical recommendations, and have not been verified by medical professionals. Do not use them as the basis for any health decisions.
Notable threads from Reddit and peptide forums, grouped by theme. Filter by category, sentiment, or peptide to find what is relevant to you.
How the community is running peptides: doses, stacks, cycles, routes.
A biohacking-community thread asking about CJC-1295 without DAC, likely covering dosing, timing, and how the shorter-acting form is used in reported GH-secretagogue protocols.
A discussion of the widely used CJC-1295 plus Ipamorelin combination, the classic GHRH-analog-plus-GHRP pairing, likely covering reported dosing schedules and expected effects.
A user asks whether the CJC-1295 plus Ipamorelin stack is better suited to a bulking or a cutting phase, inviting community input on how GH-secretagogue effects fit different body-composition goals.
A comparison thread weighing CJC-1295 (no DAC) plus Ipamorelin against Tesamorelin plus Ipamorelin, asking which GHRH-analog pairing the community regards as more effective for their goals.
A thread on the CJC-1295 plus Ipamorelin combination, likely seeking or sharing reported protocols for the popular GH-secretagogue stack.
Reported adverse experiences and safety concerns.
A first-person report of an allergic-type reaction after using the CJC-1295 plus Ipamorelin stack, likely seeking input on whether the reaction stems from the peptides themselves, excipients, or product quality.
A r/Biohacking user reports side effects after starting a CJC-1295 and Ipamorelin stack, a commonly reported protocol pairing a GHRH analog with a ghrelin-receptor agonist. The thread invites comparison with others' experiences of early-stage effects such as water retention, fatigue, injection-site reactions or appetite changes that are frequently discussed with this combination.
A user who recently began a CJC-1295 and ipamorelin combination describes side effects experienced in the early weeks and asks whether others have seen the same. The thread invites comparison of reported protocols and typical early-phase reactions such as water retention, tingling, or fatigue.
A user reports a suspected allergic reaction, possibly anaphylaxis, after injecting a CJC-1295/ipamorelin blend and asks whether others have experienced the same. The thread is an adverse-event report seeking community input.
A first-time user reports unexpected sensations shortly after injecting a CJC-1295 (no DAC) and ipamorelin combination at a stated 10+10mg dose and asks the community whether this reaction is typical. The dose described is far above commonly reported protocols for these GH secretagogues, which is itself a notable data point for first-dose adverse-experience reports.
Community discussion of studies and data.
A community explainer contrasting CJC-1295 DAC with the no-DAC form (Mod GRF 1-29), focusing on the one structural modification that separates them and summarizing what the published research says about half-life and GH-release patterns.
An installment in the same educational biohacking series, this post covers CJC-1295, a GHRH analog often paired with ipamorelin in reported protocols. The post reads as informational; no comment discussion was captured.
A comparison thread contrasting tesamorelin and CJC-1295 as growth hormone secretagogues, discussing which profile suits different research contexts.
A discussion contrasting GHK-Cu (a copper peptide discussed mainly for skin and repair contexts) with CJC-1295 (a growth-hormone-releasing analog), pushing back on the community habit of grouping mechanistically distinct peptides into one category.